Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Surmodics Inc (SRDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 303,220
  • Shares Outstanding, K 13,270
  • Annual Sales, $ 71,370 K
  • Annual Income, $ 9,990 K
  • 36-Month Beta 1.04
  • Price/Sales 4.37
  • Price/Cash Flow 14.59
  • Price/Book 2.85

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.75 +0.44%
on 04/28/17
25.10 -8.96%
on 04/26/17
-0.55 (-2.35%)
since 03/28/17
3-Month
21.90 +4.34%
on 03/28/17
26.40 -13.45%
on 02/02/17
-1.95 (-7.86%)
since 01/27/17
52-Week
19.86 +15.06%
on 05/02/16
30.75 -25.69%
on 10/04/16
+2.35 (+11.46%)
since 04/28/16

Most Recent Stories

More News
Surmodics to Webcast Second Quarter 2017 Earnings Conference Call on April 27

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its...

SRDX : 22.85 (-2.77%)
Surmodics to Present at Oppenheimer Healthcare Conference

Surmodics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief...

SRDX : 22.85 (-2.77%)
Why Is Surmodics (SRDX) Down 2.7% Since the Last Earnings Report?

Surmodics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SRDX : 22.85 (-2.77%)
Surmodics Announces 2017 Annual Shareholders Meeting

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that its virtual Annual Meeting of Shareholders...

SRDX : 22.85 (-2.77%)
SurModics (SRDX) Beats Earnings & Revenue Estimates in Q1

Surmodics, Inc. (SRDX) reported earnings of 19 cents per share in the first-quarter of fiscal 2017 surpassing the Zacks Consensus Estimate of 9 cents.

DXTR : 0.79 (-1.25%)
SRDX : 22.85 (-2.77%)
GKOS : 47.53 (+0.36%)
AVGR : 0.56 (-1.75%)
Surmodics Reports First Quarter Fiscal 2017 Results

--GAAP EPS of $0.17, Non-GAAP EPS of $0.19

SRDX : 22.85 (-2.77%)
Post Earnings Coverage as Neogen's Q2 Net Income Rose 23 Percent

Upcoming AWS Coverage on Surmodics Post-Earnings Results

SRDX : 22.85 (-2.77%)
NEOG : 62.33 (-2.14%)
SurModics (SRDX) Beats Q4 Earnings & Revenues Estimates

SurModics' (SRDX) fourth-quarter of fiscal 2016 adjusted earnings of 26 cents per share beat the Zacks Consensus Estimate of 9 cents.

ANIK : 46.13 (+0.76%)
SRDX : 22.85 (-2.77%)
VNDA : 15.25 (+0.33%)
CBM : 59.35 (+1.28%)
Surmodics Reports Fourth Quarter Fiscal 2016 Results

--GAAP EPS of $0.20, Non-GAAP EPS of $0.26

SRDX : 22.85 (-2.77%)
Surmodics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief...

SRDX : 22.85 (-2.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Support & Resistance

2nd Resistance Point 23.98
1st Resistance Point 23.42
Last Price 22.85
1st Support Level 22.52
2nd Support Level 22.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.